chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State  for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD date 04/07/2022 administered on 4/22/2022. Pfizer could not provide stability data beyond 04/09/2022 and recommended revaccination
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was Cardinal refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State of Colorado for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 66.0
Sex: M
Vaccine: COVID19, PNC20
Symptoms: Antinuclear antibody negative, Blood creatine phosphokinase normal, Blood test, Borrelia test negative, C-reactive protein increased
Clinical narrative: I GOT THE NORMAL ACHYNESS I USUALLY GET WITH COVID SHOTS IT WAS A BIT WORSE THE FIRST NIGHT THAN USUAL I THAN STARTED GETTING GRADUALLY WORSE AND WORSE I FINALLY QUIT THINKING IT WOULD GET BETTER AND WENT TO THE HOSPITAL URGENT CARE MAY 15TH. THEY TOOK A LOT OF BLOOD TESTS AND GAVE ME NO TREATMENT
Age: 66.0
Sex: M
Vaccine: COVID19, PNC20
Symptoms: Pain, Red blood cell sedimentation rate increased, Rheumatoid factor negative
Clinical narrative: I GOT THE NORMAL ACHYNESS I USUALLY GET WITH COVID SHOTS IT WAS A BIT WORSE THE FIRST NIGHT THAN USUAL I THAN STARTED GETTING GRADUALLY WORSE AND WORSE I FINALLY QUIT THINKING IT WOULD GET BETTER AND WENT TO THE HOSPITAL URGENT CARE MAY 15TH. THEY TOOK A LOT OF BLOOD TESTS AND GAVE ME NO TREATMENT
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD date 04/07/2022 administered on 4/22/2022. Pfizer could not provide stability data beyond 04/09/2022 and recommended revaccination
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was inadvertently given a 0.5ml dose (instead of the authorized 0.25ml dose) for her booster dose.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure normal, Heart rate normal, Loss of consciousness, Oxygen saturation
Clinical narrative: Patient went to hair salon after event.  Patients father thought she had a seizure, but It sounded to me like she passed out.  We gave her a cold compress.  I stayed with until the ambulance was ready to leave, and she was awake and filling better.  She did not hit her head.  Her father caught her.  and laid her down.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Autoimmune disorder, Condition aggravated, Death, Fall
Clinical narrative: I am completing this for my sister, who died today 5/5/22.  She told me that following the shot, she became very sick and was in bed in pain for 2 weeks. Before the shot, she was relatively healthy, working full time, was active in her community and garden.  Following the shot, over the next months, she told me she suffered from the following: High Blood Pressure, Worsening Eye Vision Health, Anxiety and Panic Attacks, Worsening Neuropathy. A Fall that broke her leg, necessitating a rod placed in her leg with surgery, Edema, Rash, Autoimmune Issue, Incontinence, Jaundice,and Kidney dysfunction,finally Liver Failure.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic failure, Hypertension, Incontinence, Jaundice, Limb operation
Clinical narrative: I am completing this for my sister, who died today 5/5/22.  She told me that following the shot, she became very sick and was in bed in pain for 2 weeks. Before the shot, she was relatively healthy, working full time, was active in her community and garden.  Following the shot, over the next months, she told me she suffered from the following: High Blood Pressure, Worsening Eye Vision Health, Anxiety and Panic Attacks, Worsening Neuropathy. A Fall that broke her leg, necessitating a rod placed in her leg with surgery, Edema, Rash, Autoimmune Issue, Incontinence, Jaundice,and Kidney dysfunction,finally Liver Failure.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lower limb fracture, Malaise, Medical device implantation, Neuropathy peripheral, Oedema
Clinical narrative: I am completing this for my sister, who died today 5/5/22.  She told me that following the shot, she became very sick and was in bed in pain for 2 weeks. Before the shot, she was relatively healthy, working full time, was active in her community and garden.  Following the shot, over the next months, she told me she suffered from the following: High Blood Pressure, Worsening Eye Vision Health, Anxiety and Panic Attacks, Worsening Neuropathy. A Fall that broke her leg, necessitating a rod placed in her leg with surgery, Edema, Rash, Autoimmune Issue, Incontinence, Jaundice,and Kidney dysfunction,finally Liver Failure.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Panic attack, Rash, Renal impairment, Visual impairment
Clinical narrative: I am completing this for my sister, who died today 5/5/22.  She told me that following the shot, she became very sick and was in bed in pain for 2 weeks. Before the shot, she was relatively healthy, working full time, was active in her community and garden.  Following the shot, over the next months, she told me she suffered from the following: High Blood Pressure, Worsening Eye Vision Health, Anxiety and Panic Attacks, Worsening Neuropathy. A Fall that broke her leg, necessitating a rod placed in her leg with surgery, Edema, Rash, Autoimmune Issue, Incontinence, Jaundice,and Kidney dysfunction,finally Liver Failure.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Asthenia, Blood test, Computerised tomogram, Condition aggravated
Clinical narrative: very dizzy, felt high/drunk/stoned for months, major headache ,confusion, loss of short and long term memory, unable to control my body, tremors, shakes, legs wouldnt move at times, major fatigue, vert weak, at times i couldnt even hold a cup. At times I couldnt get up out of a chair or a bed. neurological  functional movement disorder. I had pots previously but that added to this and made me worse. i have better days and really bad days.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dizziness, Euphoric mood, Fatigue, Feeling abnormal
Clinical narrative: very dizzy, felt high/drunk/stoned for months, major headache ,confusion, loss of short and long term memory, unable to control my body, tremors, shakes, legs wouldnt move at times, major fatigue, vert weak, at times i couldnt even hold a cup. At times I couldnt get up out of a chair or a bed. neurological  functional movement disorder. I had pots previously but that added to this and made me worse. i have better days and really bad days.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling drunk, Headache, Magnetic resonance imaging, Mobility decreased, Movement disorder
Clinical narrative: very dizzy, felt high/drunk/stoned for months, major headache ,confusion, loss of short and long term memory, unable to control my body, tremors, shakes, legs wouldnt move at times, major fatigue, vert weak, at times i couldnt even hold a cup. At times I couldnt get up out of a chair or a bed. neurological  functional movement disorder. I had pots previously but that added to this and made me worse. i have better days and really bad days.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nervous system disorder, Postural orthostatic tachycardia syndrome, Tremor
Clinical narrative: very dizzy, felt high/drunk/stoned for months, major headache ,confusion, loss of short and long term memory, unable to control my body, tremors, shakes, legs wouldnt move at times, major fatigue, vert weak, at times i couldnt even hold a cup. At times I couldnt get up out of a chair or a bed. neurological  functional movement disorder. I had pots previously but that added to this and made me worse. i have better days and really bad days.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Cough, Dyspnoea, Fatigue, Mobility decreased
Clinical narrative: About 5 days after second vaccination, I was in bed for about a week and a half and I definitely had shortness of breath issues, coughing, and a fever as well. Really intense fatigue and general pain as well. I began to notice bruising on my legs that were extremely large and looked really bad however I was fine. I did seek out medical care, and during my telehealth and with recent lab work for platelet check and noticed nothing wrong. If I kept bruising, I was directed to contact my pcp and had no evidence of clotting at the time. My symptoms did start to improve however it took a very long time unfortunately. The bruising was the only symptoms that continued to stick around for over a month. I did get bruising after receiving my Moderna booster vaccine and it was a lot less in comparison to the Pfizer vaccines I had prior. Coughing and trouble breathing did happen to come back as well however I recovered from my symptoms in about 4 days.  After receiving my vaccines I do want to note that my symptoms with Long Covid have slowly dissipated in severity after receiving the vaccines.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Platelet count normal, Pyrexia
Clinical narrative: About 5 days after second vaccination, I was in bed for about a week and a half and I definitely had shortness of breath issues, coughing, and a fever as well. Really intense fatigue and general pain as well. I began to notice bruising on my legs that were extremely large and looked really bad however I was fine. I did seek out medical care, and during my telehealth and with recent lab work for platelet check and noticed nothing wrong. If I kept bruising, I was directed to contact my pcp and had no evidence of clotting at the time. My symptoms did start to improve however it took a very long time unfortunately. The bruising was the only symptoms that continued to stick around for over a month. I did get bruising after receiving my Moderna booster vaccine and it was a lot less in comparison to the Pfizer vaccines I had prior. Coughing and trouble breathing did happen to come back as well however I recovered from my symptoms in about 4 days.  After receiving my vaccines I do want to note that my symptoms with Long Covid have slowly dissipated in severity after receiving the vaccines.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD date 04/07/2022 administered on 4/11/2022. Pfizer could not provide stability data beyond 04/09/2022 and recommended revaccination
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Malaise, Oropharyngeal pain
Clinical narrative: COVID break through case. I received my 2nd booster shot on 04/01/2022 and my adverse event started on 05/05/2022. From 05/06/2022-05/08/2022 I had a sore throat, cough headache, congestion, and runny nose. On the night of 05/06/2022 I tested negative for COVID. On the 05/09/2022 I went to the pharmacy and did a PCR test the result was positive. I went to the urgent care for an insect bite they gave me antibiotics. On the 05/09/2022 I went to the clinic because I wasn't feeling well and I had a PCR test done at the pharmacy for COVID. I didn't call my doctor or see my doctor but I took Advil for sore throat and headache and I also took Claritin D. It helped with runny nose. I started feeling better by Friday 05/13/2022 I had less of all of my symptoms.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID break through case. I received my 2nd booster shot on 04/01/2022 and my adverse event started on 05/05/2022. From 05/06/2022-05/08/2022 I had a sore throat, cough headache, congestion, and runny nose. On the night of 05/06/2022 I tested negative for COVID. On the 05/09/2022 I went to the pharmacy and did a PCR test the result was positive. I went to the urgent care for an insect bite they gave me antibiotics. On the 05/09/2022 I went to the clinic because I wasn't feeling well and I had a PCR test done at the pharmacy for COVID. I didn't call my doctor or see my doctor but I took Advil for sore throat and headache and I also took Claritin D. It helped with runny nose. I started feeling better by Friday 05/13/2022 I had less of all of my symptoms.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State  for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: I got COVID symptoms on May 16, 2022 and tested positive the next day. I received my second booster (4th overall COVID shot) on April 7, 2022. I don't believe the shot had anything to do with the symptoms I got one month later.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 12.0
Sex: F
Vaccine: UNK
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered
Clinical narrative: Client received 2nd Covid 19 booster dose by accident. Client was checked in by clerk who verified  client's vaccination status. Client brought to nurse. Vaccination given. About 10 minutes later clerk said that client had received a booster dose already. Apparently clerk checked county data base only before clearing client to nurse. While client & mother were receiving vaccinations, clerk checked system. that is when she noticed that client had already received a booster shot from another provider.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given Johnson and Johnson vaccine as a booster dose (third dose). 0.5 ml was given. No reactions./side effects.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dizziness, Headache, Influenza like illness, Mobility decreased
Clinical narrative: I had reactions FOR DAYS from BOTH vaccinations AND the BOOSTER!  Reactions included fever, muscle aches, dizziness, flu-like symptoms, exasperation of my MS for days, could not get out of bed for 3 days.  My heart started to race and with it my head pain.  My heart is now subject to Several weeks later some of the symptoms continued.  And my heart palpitations have come and gone since the first vaccine.  Never had them before!
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Multiple sclerosis relapse, Myalgia, Palpitations, Pyrexia
Clinical narrative: I had reactions FOR DAYS from BOTH vaccinations AND the BOOSTER!  Reactions included fever, muscle aches, dizziness, flu-like symptoms, exasperation of my MS for days, could not get out of bed for 3 days.  My heart started to race and with it my head pain.  My heart is now subject to Several weeks later some of the symptoms continued.  And my heart palpitations have come and gone since the first vaccine.  Never had them before!
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD date 04/07/2022 administered on 4/12/2022. Pfizer could not provide stability data beyond 04/09/2022 and recommended revaccination
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Arthralgia, Inflammation, Neck pain, Pain, X-ray
Clinical narrative: pain in shoulder up to neck in area that would support Bursal injection and inflammation with pain on any shoulder motion.  he started Aleve BID -- we changed that to Medrol dose pak and gave him intraBursal injection of depo-medrol and lidocaine on 5/20/2022
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State  for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was given the J and J vaccine as the booster dose (third dose). 0.5 ml was given. Patient was persistent and still wanted to this vaccine. No side effects as of today.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 0.75
Sex: M
Vaccine: HEP
Symptoms: Pruritus, Urticaria
Clinical narrative: itchy hives throughout body on evening of 5/16/2022, treated with OTC Benadryl and Prednisolone x 3 days, outcome unknown at this time
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State  for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: BUD date 04/07/2022 administered on 4/13/2022. Pfizer could not provide stability data beyond 04/09/2022 and recommended revaccination
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.